XML 117 R99.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION PLANS (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation $ 52 $ 60 $ 35
Tax benefit related to stock-based compensation $ 13 14 9
Shares authorized under stock-based compensation plans (in shares) 20,000,000    
Shares remaining available for future grants (shares) 3,000,000    
Stock options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation $ 1 $ 2 $ 3
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected volatility   46.00% 44.00%
Expected term   6 years 6 years
Risk-free interest rate   3.64% 1.91%
Expected dividend yield   0.00% 0.00%
Weighted-average grant date fair value per share (in dollars per share)   $ 16.77 $ 23.36
Estimated fair value of options granted (millions)   $ 1 $ 4
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 1,161,430    
Granted (in Shares) 0    
Exercised (in shares) (27,516)    
Canceled (in shares) (29,380)    
Forfeited or expired (in shares) (2,960)    
Outstanding, ending balance (in shares) 1,101,574 1,161,430  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Outstanding, beginning balance, Weighted-Average Exercise Price Per Share (in dollars per share) $ 61.36    
Granted, Weighted-Average Exercise Price Per Share (in dollars per share) 0    
Exercised, Weighted-Average Exercise Price Per Share (in dollars per share) 41.05    
Canceled, Weighted-Average Exercise Price Per Share (in dollars per share) 55.95    
Fofeited or expired, Weighted-Average Exercise Price Per Share (in dollars per share) 55.51    
Outstanding, ending balance, Weighted-Average Exercise Price Per Share (in dollars per share) $ 62.03 $ 61.36  
Outstanding, Weighted-Average Contractual Life 4 years 1 month 6 days 5 years 1 month 6 days  
Outstanding, Aggregate Intrinsic Value $ 5 $ 0  
Exercisable, Outstanding (in shares) 973,512    
Exercisable, Weighted-Average Exercise Price Per Share (in dollars per share) $ 62.99    
Exercisable, Weighted-Average Contractual Life 3 years 9 months 18 days    
Exercisable, Aggregate Intrinsic Value $ 4    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Vested or expected to vest, Shares 1,101,483    
Vested or expected to vest, Weighted-Average Exercise Price Per Share (in dollars per share) $ 62.03    
Vested or expected to vest, Weighted-Average Contractual Life 4 years 1 month 6 days    
Vested or expected to vest, Aggregate Intrinsic Value $ 5    
Intrinsic value of option exercises 1 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 4 4
Stock awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation 31 $ 39 14
Unrecognized stock-based compensation for non-vested options and awards $ 34    
Unrecognized stock-based compensation awards weighted-average period 1 year 7 months 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, beginning balance (in shares) 868,784    
Granted (in shares) 1,125,225    
Vested (in shares) (552,498)    
Forfeited (in shares) (75,809)    
Non-vested, ending balance (in shares) 1,365,702 868,784  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Non-vested, beginning balance, Weighted-Average Grant Date Fair Value (in dollars per share) $ 51.95    
Granted, Weighted-Average Grant Date Fair Value (in dollars per share) 39.16    
Vested, Weighted-Average Grant Date Fair Value (in dollars per share) 47.52    
Forfeited, Weighted-Average Grant Date Fair Value (in dollars per share) 52.93    
Non-vested, ending balance, Weighted-Average Price Per Share (in dollars per share) $ 43.80 $ 51.95  
Non-vested, Weighted-Average Contractual Life 1 year 7 months 6 days 1 year 8 months 12 days  
Non-vested, Total Instrinsic Value (in dollars) $ 90 $ 34  
Deferred stock awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation 1 1 1
Employee stock purchase plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation $ 19 $ 18 $ 17
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Granted (in shares) 2,219,160 1,855,608 1,292,489
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent 85.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate 10.00%    
Performance Based Restricted Stock Units [Member] | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Performance Award Payout, Percentage of Target Level 0.00%    
Performance Based Restricted Stock Units [Member] | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Performance Award Payout, Percentage of Target Level 200.00%